MTOR and hepatocellular carcinoma: TMAO upregulates POSTN and activates the ILK/AKT/mammalian target of rapamycin (mTOR) pathway in HCC, and the high expression level of POSTN is closely related to neutrophil infiltration of HCC patients (Wu et al., 2022).